申请人:Dana-Farber Cancer Institute, Inc.
公开号:EP3885343A1
公开(公告)日:2021-09-29
The present disclosure provides compounds of Formula (II).
The compounds described herein are inhibitors of histone methyltransferases (e.g., enhancer of zeste homolog 1 (EZH1) and enhancer of zeste homolog 2 (EZH2)) and are useful in treating and/or preventing a broad range of diseases (e.g., proliferative diseases). Also provided in the present disclosure are pharmaceutical compositions, kits, methods, and uses including or using a compound described herein. Further provided in the present disclosure are methods of identifying EZH1 and/or EZH2 inhibitors.
本公开提供了式(II)化合物。
本文所述化合物是组蛋白甲基转移酶(如泽斯特同源增强子 1 (EZH1) 和泽斯特同源增强子 2 (EZH2))的抑制剂,可用于治疗和/或预防多种疾病(如增殖性疾病)。本公开还提供了包括或使用本文所述化合物的药物组合物、试剂盒、方法和用途。本公开还提供了鉴定EZH1和/或EZH2抑制剂的方法。